David J Meyers1, Megan B Cole, Momotazur Rahman, Yoojin Lee, William Rogers, Roee Gutman, Ira B Wilson. 1. aDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island bDepartment of Health Law, Policy, & Management, Boston University School of Public Health cInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts dDepartment of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.
Abstract
OBJECTIVE: While antiretroviral therapy (ART) is essential to patients with HIV, there is substantial variation in adherence nationally. We assess how provider and practice factors contribute to successful HIV ART adherence. DESIGN: We used Medicaid Analytic Extract claims from 2008 to 2012. We attributed patients with HIV to the provider that provided the plurality of HIV-related services or primary care in a given year and assigned these providers to a medical practice based on the National Provider Identifier registry file. We fit successive linear hierarchical models with patient, provider, and practice characteristics to partition the variation in adherence driven by each factor. Our unit of analysis was the patient-year. SETTING: Fourteen US states with the highest HIV prevalence. PARTICIPANTS: A total of 111 013 patient-years representing 60 496 Medicaid enrollees living with HIV attributed to 4930 providers and 1960 practices. MAIN OUTCOME MEASURE: Percentage of year individual patients were adherent to an ART regimen. RESULTS: Provider and practice random effects jointly explained 6.8% of variation in adherence with patient differences accounted for 45.2% of the variation. Patients seen by generalists and other specialists had a 1.6 [95% confidence interval (CI): 0.6-2.5] and 5.1 (95% CI: 4.1-6.1) percentage point greater adherence than those seen by infectious disease specialists (P < 0.001). Every additional year a patient saw the same provider was associated with a 6% increase in adherence (95% CI: 5.7-6.3). CONCLUSION: There is substantial variation in ART adherence attributable to providers and practices and between provider specialties. To improve ART adherence for patients living with HIV, structural aspects of care should be considered.
OBJECTIVE: While antiretroviral therapy (ART) is essential to patients with HIV, there is substantial variation in adherence nationally. We assess how provider and practice factors contribute to successful HIV ART adherence. DESIGN: We used Medicaid Analytic Extract claims from 2008 to 2012. We attributed patients with HIV to the provider that provided the plurality of HIV-related services or primary care in a given year and assigned these providers to a medical practice based on the National Provider Identifier registry file. We fit successive linear hierarchical models with patient, provider, and practice characteristics to partition the variation in adherence driven by each factor. Our unit of analysis was the patient-year. SETTING: Fourteen US states with the highest HIV prevalence. PARTICIPANTS: A total of 111 013 patient-years representing 60 496 Medicaid enrollees living with HIV attributed to 4930 providers and 1960 practices. MAIN OUTCOME MEASURE: Percentage of year individual patients were adherent to an ART regimen. RESULTS: Provider and practice random effects jointly explained 6.8% of variation in adherence with patient differences accounted for 45.2% of the variation. Patients seen by generalists and other specialists had a 1.6 [95% confidence interval (CI): 0.6-2.5] and 5.1 (95% CI: 4.1-6.1) percentage point greater adherence than those seen by infectious disease specialists (P < 0.001). Every additional year a patient saw the same provider was associated with a 6% increase in adherence (95% CI: 5.7-6.3). CONCLUSION: There is substantial variation in ART adherence attributable to providers and practices and between provider specialties. To improve ART adherence for patients living with HIV, structural aspects of care should be considered.
Authors: Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum Journal: Health Serv Res Date: 2018-10-14 Impact factor: 3.402
Authors: Becky L Genberg; William H Rogers; Yoojin Lee; Danya M Qato; David D Dore; David S Hutchins; Troyen Brennan; Olga S Matlin; Ira B Wilson Journal: Pharmacoepidemiol Drug Saf Date: 2016-05-13 Impact factor: 2.890
Authors: W L Holzemer; I B Corless; K M Nokes; J G Turner; M A Brown; G M Powell-Cope; J Inouye; S B Henry; P K Nicholas; C J Portillo Journal: AIDS Patient Care STDS Date: 1999-03 Impact factor: 5.078
Authors: Alan T Rodriguez-Penney; Jennifer E Iudicello; Patricia K Riggs; Katie Doyle; Ronald J Ellis; Scott L Letendre; Igor Grant; Steven Paul Woods Journal: AIDS Patient Care STDS Date: 2013-01 Impact factor: 5.078
Authors: Ira B Wilson; David R Bangsberg; Jie Shen; Jane M Simoni; Nancy R Reynolds; Kathy Goggin; Robert Gross; Julia H Arnsten; Robert H Remien; Judith A Erlen; Honghu Liu Journal: J Acquir Immune Defic Syndr Date: 2013-12-15 Impact factor: 3.731
Authors: Julie C Lauffenburger; William H Shrank; Asaf Bitton; Jessica M Franklin; Robert J Glynn; Alexis A Krumme; Olga S Matlin; Edmund J Pezalla; Claire M Spettell; Gregory Brill; Niteesh K Choudhry Journal: Ann Intern Med Date: 2016-11-15 Impact factor: 25.391